5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The UAE Cardiovascular Devices Market provides a detailed analysis, trends and forecast on various segments of the market which is segmented by Device Type (Diagnostic and Monitoring Device, Therapeutic and Surgical Devices) and Geography.
2018 - 2026
The cardiovascular devices market is expected to show significant growth in UAE during the forecast period, 2020-2025. The key contributors to the market growth are the growing burden of cardiovascular diseases and technological advancements. Cardiovascular diseases are one of the leading causes of mortality and morbidity in the UAE. According to the study of Hamdan Medical Journal, 2018, approximately 22% of the cardiovascular deaths were accounted for acute myocardial infarction (AMI), 16% for cerebrovascular disease, 6% for ischaemic heart disease and 5% for hypertension. The sedentary lifestyle among the population is expected to add a burden. Hence, the importance of early diagnosis and treatment is rising thereby boosting the cardiovascular devices market growth in UAE.
Cardiovascular devices are utilized to treat cardiovascular ailments that incorporate various issues. The Cardiovascular Devices Market report is segmented by Device Type and Geography.
|By Device Type|
Report scope can be customized per your requirements. Click here.
Diagnostic and Monitoring segments include an electrocardiogram (ECG), remote cardiac monitoring, and others. An electrocardiogram is used for measuring the electrical activity of the heart to analyze if it's working properly or not. The technological advancements occurring in these devices is driving the growth. The Ministry of Health and Prevention (MoHAP), recently (2020) introduced AI-based device monitoring cardiac arrhythmia in the Arab Health 2020. It is a type of ECG that is made with an aim to curb heart diseases even before they occur. Furthermore, the prevalence of hypertension is also increasing. According to the Journal of Hypertension, 2017, the prevalence of hypertension in the Middle-east Countries was around 30%. Hence, the demand for diagnostic and monitoring devices in this market is expected to increase.
To understand key trends, Download Sample Report
The major players in the market are Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences, GE Healthcare, W. L. Gore & Associates, Inc., Medtronic PLC, Biotronik, Siemens Healthineers AG, and Canon Medical Systems Corporation.
1.1 Study Assumptions
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Technological Advancements
4.2.2 Increasing Burden of Cardiovascular Diseases
4.2.3 Increased Preference of Minimally Invasive Procedures
4.3 Market Restraints
4.3.1 Stringent Regulatory Policies
4.3.2 High Cost of Instruments and Procedures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Diagnostic and Monitoring Devices
22.214.171.124 Electrocardiogram (ECG)
126.96.36.199 Remote Cardiac Monitoring
188.8.131.52 Other Diagnostic and Monitoring Devices
5.1.2 Therapeutic and Surgical Devices
184.108.40.206 Cardiac Assist Devices
220.127.116.11 Cardiac Rhythm Management Device
18.104.22.168 Other Therapeutic and Surgical Devices
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Al Naghi Medical Co.
6.1.3 Cardinal Health Inc.
6.1.4 Atlas Medical LLC
6.1.5 GE Healthcare
6.1.6 W. L. Gore & Associates, Inc.
6.1.7 Medtronic PLC
6.1.9 Siemens Healthineers AG
6.1.10 Advanced Healthcare LLC
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments